Option Care Health, Inc. reported significant financial results for the second quarter of 2025, with net revenue reaching $1.416 billion, a 15.4% increase from $1.227 billion in the same period last year. For the first half of 2025, the company generated $2.749 billion in revenue, up 15.8% from $2.373 billion in the first half of 2024. The gross profit for the second quarter was $269 million, reflecting a gross profit margin of 19.0%, down from 20.3% in the prior year. The decrease in margin was attributed to higher costs associated with certain therapies and a reduction in procurement spread.
In terms of profitability, Option Care Health reported a net income of $50.5 million for the second quarter, a decrease from $53 million in the same quarter of 2024. For the first half of 2025, net income was $97.3 million, slightly down from $97.8 million in the previous year. The company’s effective tax rate for the second quarter was 26.6%, compared to 26.4% in the same period last year, primarily due to differences in federal and state tax rates and non-deductible expenses.
Strategically, Option Care Health completed the acquisition of Intramed Plus, Inc. on January 24, 2025, for a net purchase price of $117.2 million. This acquisition is expected to enhance the company’s operational efficiencies and expand its service offerings. The company operates a national network of 190 locations, including 89 full-service pharmacies and 101 stand-alone ambulatory infusion suites, which positions it well for continued growth in the infusion therapy market.
Operationally, the company reported an increase in customer engagement, with a notable rise in the volume of patient services driven by shifts in the competitive landscape. The total employee headcount has also increased, reflecting the company’s commitment to expanding its workforce to support growth. However, cash and cash equivalents decreased to $198.8 million as of June 30, 2025, down from $412.6 million at the end of 2024, primarily due to increased cash outflows for share repurchases and the Intramed Plus acquisition.
Looking ahead, Option Care Health anticipates continued growth in its infusion services segment, supported by its strategic acquisitions and operational enhancements. The company remains focused on leveraging its existing infrastructure to control costs while expanding its service offerings to meet the evolving needs of patients and healthcare providers.
About Option Care Health, Inc.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.